Immunoassay development guidelines for neurodegenerative disorders:lessons from a failed pS129-α-synuclein electrochemiluminescence immunoassay
Hash Brown Taha
Alanna Morris
Abstract：An aging population is a double-edged sword. On one hand, advancements in biotechnology and healthcare allow more people to enjoy longer lives. On the other hand, increases in the aging population accompany a surge in age-associated diseases, particularly neurodegenerative disorders. Since aging is the primary risk factor for many neurodegenerative disorders, living longer does not necessarily equate to maintaining a reasonable quality of life (Feigin et al., 2020).
Machine-generated Keywords：
Publication Date：2025-10-27
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 2906-2908 )